DE69435170D1 - Extrakorporeale Vorrichtungen zur Adsorption durch Affinität - Google Patents

Extrakorporeale Vorrichtungen zur Adsorption durch Affinität

Info

Publication number
DE69435170D1
DE69435170D1 DE69435170T DE69435170T DE69435170D1 DE 69435170 D1 DE69435170 D1 DE 69435170D1 DE 69435170 T DE69435170 T DE 69435170T DE 69435170 T DE69435170 T DE 69435170T DE 69435170 D1 DE69435170 D1 DE 69435170D1
Authority
DE
Germany
Prior art keywords
extrakorporeal
affinity
adsorption
devices
extrakorporeal devices
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69435170T
Other languages
English (en)
Inventor
Meir Strahilevitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69435170D1 publication Critical patent/DE69435170D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3475—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate with filtrate treatment agent in the same enclosure as the membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/362—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits changing physical properties of target cells by binding them to added particles to facilitate their subsequent separation from other cells, e.g. immunoaffinity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
DE69435170T 1993-07-23 1994-07-20 Extrakorporeale Vorrichtungen zur Adsorption durch Affinität Expired - Lifetime DE69435170D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/097,378 US5753227A (en) 1993-07-23 1993-07-23 Extracorporeal affinity adsorption methods for the treatment of atherosclerosis, cancer, degenerative and autoimmune diseases
PCT/US1994/008043 WO1995003084A2 (en) 1993-07-23 1994-07-20 Extracorporeal affinity adsorption devices

Publications (1)

Publication Number Publication Date
DE69435170D1 true DE69435170D1 (de) 2009-01-08

Family

ID=22263054

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69435170T Expired - Lifetime DE69435170D1 (de) 1993-07-23 1994-07-20 Extrakorporeale Vorrichtungen zur Adsorption durch Affinität

Country Status (6)

Country Link
US (6) US5753227A (de)
EP (1) EP0710135B1 (de)
AU (1) AU7472594A (de)
DE (1) DE69435170D1 (de)
IL (1) IL110382A (de)
WO (1) WO1995003084A2 (de)

Families Citing this family (139)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4375414A (en) * 1971-05-20 1983-03-01 Meir Strahilevitz Immunological methods for removing species from the blood circulatory system and devices therefor
US5919369A (en) * 1992-02-06 1999-07-06 Hemocleanse, Inc. Hemofiltration and plasmafiltration devices and methods
US5753227A (en) 1993-07-23 1998-05-19 Strahilevitz; Meir Extracorporeal affinity adsorption methods for the treatment of atherosclerosis, cancer, degenerative and autoimmune diseases
AUPN030794A0 (en) 1994-12-22 1995-01-27 Aruba International Pty Ltd Discontinuous plasma or serum delipidation
US7166295B1 (en) * 1995-05-26 2007-01-23 Meir Strahilevitz Methods of treatment and diagnostic visualization, particularly in cancer
US5868936A (en) * 1996-06-20 1999-02-09 Baxter International Inc. Affinity membrane system and method of using same
US6083187A (en) * 1996-09-09 2000-07-04 Kaneka Corporation Method and apparatus for treating blood
US6245038B1 (en) * 1997-01-07 2001-06-12 Helmut Borberg Method for treatment of ophthalmological diseases
US6627151B1 (en) * 1997-06-13 2003-09-30 Helmut Borberg Method for treatment diseases associated with a deterioration of the macrocirculation, microcirculation and organ perfusion
US20020159995A1 (en) * 1997-07-30 2002-10-31 Renal Tech International Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood, generated as a result of extracorporeal blood processing
US20020197249A1 (en) * 2001-04-10 2002-12-26 Renal Tech International Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood products
US20020198487A1 (en) * 2001-04-10 2002-12-26 Renal Tech International Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in physiologic fluids
US20020197250A1 (en) * 2001-04-10 2002-12-26 Renal Tech International Biocompatible devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood
US8329388B2 (en) * 1997-07-30 2012-12-11 Cytosorbents, Inc. Biocompatible devices, systems, and methods for reducing levels of proinflammatory of antiinflammatory stimulators or mediators in the blood
US6620382B1 (en) 1998-05-22 2003-09-16 Biopheresis Technologies, Llc. Method and compositions for treatment of cancers
US8197430B1 (en) 1998-05-22 2012-06-12 Biopheresis Technologies, Inc. Method and system to remove cytokine inhibitor in patients
US6287516B1 (en) 1998-07-10 2001-09-11 Immunocept, L.L.C. Hemofiltration systems, methods, and devices used to treat inflammatory mediator related disease
US20040199099A1 (en) * 1998-07-10 2004-10-07 Matson James R Hemofiltration systems, methods and devices used to treat inflammatory mediator related disease
AU2830400A (en) * 1999-03-05 2000-09-28 Mitsubishi Rayon Company Limited Carriers having biological substance
AU4674000A (en) * 1999-04-30 2000-11-17 Hemex Inc. Method for removing heavy metals from bone
EP1315551B1 (de) * 1999-06-03 2015-11-04 Advanced Extravascular Systems Entfernung von unerwünschten molekülen aus zirkulierendem blut in einem schritt
US6464976B1 (en) 1999-09-07 2002-10-15 Canji, Inc. Methods and compositions for reducing immune response
US6379708B1 (en) * 1999-11-20 2002-04-30 Cytologic, Llc Method for enhancing immune responses in mammals
US6736972B1 (en) 2000-03-24 2004-05-18 Immunocept, L.L.C. Method and system for providing therapeutic agents with hemofiltration for reducing inflammatory mediator related diseases
US7291122B2 (en) * 2000-03-24 2007-11-06 Immunocept, L.L.C. Hemofiltration methods for treatment of diseases in a mammal
AU2001259469A1 (en) * 2000-05-05 2001-11-20 Hemocleanse, Inc. Use of magnetic particles or other particles having relatively high density in afluid for mixing and/or leak detection
US8865172B2 (en) 2000-05-08 2014-10-21 Advanced Extravascular Systems, Inc. Method for reducing the number of unwanted molecules in bodily fluids
US6787040B2 (en) * 2000-05-16 2004-09-07 Immunocept, L.L.C. Method and system for colloid exchange therapy
US7407662B2 (en) * 2000-06-29 2008-08-05 Lipid Sciences, Inc. Modified viral particles with immunogenic properties and reduced lipid content
US7439052B2 (en) * 2000-06-29 2008-10-21 Lipid Sciences Method of making modified immunodeficiency virus particles
US7407663B2 (en) * 2000-06-29 2008-08-05 Lipid Sciences, Inc. Modified immunodeficiency virus particles
AUPQ846900A0 (en) * 2000-06-29 2000-07-27 Aruba International Pty Ltd A vaccine
US20090017069A1 (en) * 2000-06-29 2009-01-15 Lipid Sciences, Inc. SARS Vaccine Compositions and Methods of Making and Using Them
EP1317463B1 (de) * 2000-09-12 2005-03-23 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Hochtemperaturstabile siliciumborcarbidnitridkeramiken aus silylalkylborazinen, verfahren zu deren herstellung sowie deren verwendung
GB0103766D0 (en) * 2001-02-15 2001-04-04 Affitech As Diagnostic
US6706008B2 (en) 2001-03-06 2004-03-16 Baxter International Inc. Automated system and method for withdrawing compounds from blood
US6582386B2 (en) 2001-03-06 2003-06-24 Baxter International Inc. Multi-purpose, automated blood and fluid processing systems and methods
US6884228B2 (en) 2001-03-06 2005-04-26 Baxter International Inc. Automated system adaptable for use with different fluid circuits
US20020197252A1 (en) * 2001-04-10 2002-12-26 Renal Tech International Selective adsorption devices and systems
US6878127B2 (en) * 2001-04-10 2005-04-12 Renaltech International, Llc Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood
US20060060520A1 (en) * 2001-06-25 2006-03-23 Bomberger David C Systems and methods using a solvent for the removal of lipids from fluids
WO2003000381A1 (en) 2001-06-25 2003-01-03 Lipid Sciences, Inc. Hollow fiber contactor systems for removal of lipids from fluids
US6991727B2 (en) * 2001-06-25 2006-01-31 Lipid Sciences, Inc. Hollow fiber contactor systems for removal of lipids from fluids
EP1412045A4 (de) * 2001-06-25 2007-05-02 Lipid Sciences Inc Ein lösungsmittel zur entfernung von lipiden aus fluiden verwendende systeme und verfahren
FR2826975B1 (fr) * 2001-07-09 2004-06-04 Bio Merieux Utilisation de lipoproteines oxydees pour obtenir la differenciation de monocytes en cellules dendritiques matures
US7682793B2 (en) * 2001-08-01 2010-03-23 Chauhan Anil K Immune complexes
US7569025B2 (en) * 2002-04-02 2009-08-04 Scantibodies Laboratory, Inc. Methods and devices for treating severe peripheral bacterial infections
US7425331B2 (en) * 2002-04-10 2008-09-16 Protalex, Inc. Protein A methods of use
US7211258B2 (en) * 2002-04-10 2007-05-01 Protalex, Inc. Protein A compositions and methods of use
EP1507557A4 (de) * 2002-04-23 2006-06-14 Meir Strahilevitz Verfahren und vorrichtungen zum anzielen eines situs in einem säugetier und zur entfernung von spezies aus einem säugetier
EP1362605A1 (de) * 2002-05-14 2003-11-19 Bernhard Dr. Kreymann Dialysevorrichtung zur Entfernung proteingebundener Substanzen
US7455771B2 (en) * 2002-05-14 2008-11-25 Hepa Wash Gmbh Means for removing protein-bound substances
US20040102732A1 (en) * 2002-06-19 2004-05-27 Morteza Naghavi Dialysis system for treatment of vulnerable patients and methods of use
KR20050083627A (ko) * 2002-08-13 2005-08-26 아비오스 테크놀러지스 인코포레이티드 선택적 혈장 교환 치료
KR100459432B1 (ko) * 2002-08-21 2004-12-03 엘지전자 주식회사 이동통신 시스템의 핸드오버 처리방법
JP2005538148A (ja) * 2002-08-26 2005-12-15 リピド サイエンスィズ インコーポレイテッド 脱脂タンパク質粒子を使用したアルツハイマー病治療
CN102266272B (zh) 2002-11-27 2012-12-26 Dmi生物科学公司 一种个人护理组合物及其产品
WO2004071446A2 (en) * 2003-02-12 2004-08-26 Chauhan Anil K Immune complexes
US7229427B2 (en) * 2003-03-17 2007-06-12 Hemavation Irradiation and filter device for treatment of blood
US20040185041A1 (en) * 2003-03-17 2004-09-23 Henna Vation, Llc Method for extracorporeal treatment of blood
US20040186407A1 (en) * 2003-03-17 2004-09-23 Kimberly Walker Concentrator and filter apparatus for treatment of blood
US7201730B2 (en) 2003-03-17 2007-04-10 Hemavation, Llc Device and method for reducing inflammatory mediators in blood
US20040186412A1 (en) * 2003-03-17 2004-09-23 Mallett Scott R. Extracorporeal blood treatment system using ultraviolet light and filters
US20040182784A1 (en) * 2003-03-17 2004-09-23 Walker Kimberly A. Concentrator and filter based blood treatment system
US20040185426A1 (en) * 2003-03-17 2004-09-23 Mallett Scott R. Ultraviolet light and filter apparatus for treatment of blood
US7207964B2 (en) * 2003-03-17 2007-04-24 Hemavation, Llc Apparatus and method for down-regulating immune system mediators in blood
US20040182783A1 (en) * 2003-03-17 2004-09-23 Walker Kimberly A. Filter and concentrator device for treatment of blood
US7341843B2 (en) 2003-04-11 2008-03-11 Allergan, Inc. Botulinum toxin A peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy
US20080171347A1 (en) * 2003-04-11 2008-07-17 Atassi M Zouhair Determining and reducing immunoresistance to botulinum toxin therapy using botulinum toxin a peptides
US7393826B2 (en) 2003-07-03 2008-07-01 Lipid Sciences, Inc. Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
JP2007527387A (ja) * 2003-07-03 2007-09-27 リピッド サイエンシーズ，インコーポレイテッド 脂質含量の低下したｈｄｌの粒子誘導体を製造するための方法及び装置
US6960803B2 (en) * 2003-10-23 2005-11-01 Silicon Storage Technology, Inc. Landing pad for use as a contact to a conductive spacer
CN2698358Y (zh) * 2004-04-06 2005-05-11 上海江夏血液技术有限公司 血液过滤装置
KR20070007196A (ko) * 2004-04-26 2007-01-12 테바 파마슈티컬 인더스트리즈 리미티드 펙소페나딘 히드로클로라이드의 결정형 및 이의 제조 방법
DK1949915T3 (da) * 2004-04-30 2012-11-26 Biopheresis Technologies Inc Fremgangsmåde og system til fjernelse af opløselig TNFR1, TNRF2 og IL2R i patienter
RU2386967C2 (ru) * 2004-07-30 2010-04-20 Ханс-Вернер ХАЙНРИХ Устройство и способ для выделения клеток, биочастиц и/или молекул из жидкостей с целью применения у животных, в биотехнологии (включая биологическое исследование) и медицинской диагностике
WO2007001332A2 (en) 2004-08-04 2007-01-04 University Of Massachusetts Anti-pathogen immunoadhesins
US20060068454A1 (en) * 2004-09-27 2006-03-30 Sysmex Corporation Method of inactivating blood coagulation factor and blood coagulation factor-inactivated sample
US20070258992A1 (en) * 2004-10-06 2007-11-08 Atassi M Zouhair Determining and Reducing Immunoresistance to Botulinum Toxin Therapy Using Botulinum Toxin a Peptides
US7569353B2 (en) * 2004-11-04 2009-08-04 Quest Diagnostics Investments Incorporated Myeloperoxidase detection in diagnosis and prognosis of hematopoietic disorders
US20060147536A1 (en) * 2004-12-30 2006-07-06 Fiore Robert A Method for removing fluids containing dissolved or suspended carbohydrates, lipids, metals, salts, and/or toxins from biological systems
AU2006270057A1 (en) * 2005-07-18 2007-01-25 Trustees Of Boston University Method to inhibit proliferation and growth of metastases
US20070065514A1 (en) * 2005-09-22 2007-03-22 Howell Mark D Method for enhancing immune responses in mammals
KR101397386B1 (ko) 2005-12-13 2014-05-26 엑스테라 메디컬 코퍼레이션 혈액으로부터 병원성 미생물, 염증 세포 또는 염증단백질의 체외 제거를 위한 방법
DE102006012024A1 (de) * 2006-03-14 2007-09-20 Adexter Gmbh Regenerierbares Filter zur extrakorporalen Behandlung partikelhaltiger Flüssigkeiten und deren Anwendung
US7670788B2 (en) * 2006-06-01 2010-03-02 Allergan, Inc. Determining and reducing immunoresistance to a Botulinum toxin therapy using Botulinum toxin B peptides
US7691587B2 (en) * 2006-06-01 2010-04-06 Allergan, Inc. Determining and reducing immunoresistance to a botulinum toxin therapy using botulinum toxin B peptides
US20100012588A1 (en) * 2006-08-28 2010-01-21 Maciej Siewinski system and method for the extra-corporeal purification of blood of pathogenic enzymes
KR101340932B1 (ko) 2006-08-31 2013-12-13 도레이 카부시키가이샤 복합 섬유를 포함하는 흡착 담체
US20080075690A1 (en) * 2006-09-22 2008-03-27 Mark Douglas Howell Method for enhancing immune responses in mammals
US8211310B2 (en) 2006-11-20 2012-07-03 Cytosorbents, Inc. Size-selective polymer system
US9604196B2 (en) 2006-11-20 2017-03-28 Cytosorbent, Inc. Size-selective hemocompatible polymer system
US7875182B2 (en) * 2006-11-20 2011-01-25 Cytosorbents, Inc. Size-selective hemoperfusion polymeric adsorbents
EP2002855B1 (de) * 2007-06-14 2012-07-11 RenApta B.V. Künstliche Niere
US8961448B2 (en) * 2008-01-28 2015-02-24 Peter Forsell Implantable drainage device
US8430831B2 (en) 2009-02-25 2013-04-30 The Invention Science Fund I, Llc Device, system, and method for controllably reducing inflammatory mediators in a subject
US8317737B2 (en) * 2009-02-25 2012-11-27 The Invention Science Fund I, Llc Device for actively removing a target component from blood or lymph of a vertebrate subject
US8246565B2 (en) * 2009-02-25 2012-08-21 The Invention Science Fund I, Llc Device for passively removing a target component from blood or lymph of a vertebrate subject
US9216386B2 (en) * 2009-03-17 2015-12-22 Marv Enterprises, LLC Sequential extracorporeal treatment of bodily fluids
US8758286B2 (en) 2009-12-01 2014-06-24 Exthera Medical Corporation Method for removing cytokines from blood with surface immobilized polysaccharides
ES2784183T3 (es) * 2009-12-08 2020-09-22 Univ Illinois Procedimientos de uso y aparato para modulación inmunitaria de células madre
US20110295175A1 (en) * 2010-03-16 2011-12-01 Marv Enterprises Llc Sequential Extracoporeal Treatment of Bodily Fluids
WO2012112724A1 (en) 2011-02-15 2012-08-23 Exthera Medical, Llc Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
EP2696961B1 (de) 2011-04-13 2019-02-13 Fenwal, Inc. Systeme zur verwendung und steuerung eines automatisierten separators mit adsorptionssäulen
WO2012141889A1 (en) 2011-04-13 2012-10-18 Fenwal, Inc. Centrifugation system with red blood cell barrier
US20140193514A1 (en) * 2011-08-19 2014-07-10 Marv Enterprises Method for the Treatment of Cancer
US20140251917A1 (en) * 2011-09-22 2014-09-11 Marv Enterprises,LLC Method for the treatment of multiple sclerosis
SE1200356A1 (sv) 2011-10-30 2013-05-01 Kurt Nilsson Polymerbaserad produkt och användning
WO2013148405A2 (en) * 2012-03-27 2013-10-03 Felder Mitchell S Treatment for atherosclerosis
WO2013177096A1 (en) * 2012-05-22 2013-11-28 Felder Mitchell S A method for the treatment of cancer
WO2013181016A2 (en) * 2012-05-27 2013-12-05 Felder Mitchell S Treatment for the rapid amelioration of clinical depression
WO2013188073A1 (en) * 2012-06-13 2013-12-19 Exthera Medical, Llc Use of heparin and carbohydrates to treat cancer
US9717841B2 (en) 2012-09-11 2017-08-01 Gary L. McNeil Closed-circuit device and methods for isolation, modification, and re-administration of specific constituents from a biological fluid source
JP6648009B2 (ja) 2013-06-24 2020-02-14 エクステラ・メディカル・コーポレーション マンノース被覆基材を含有する血液濾過システム
ES2799398T3 (es) 2013-11-08 2020-12-17 Exthera Medical Corp Métodos para diagnosticar enfermedades infecciosas usando medios de adsorción
MX2016013873A (es) 2014-04-24 2017-03-09 Exthera Medical Corp Metodo para eliminar bacterias de la sangre usando alta velocidad de flujo.
US20170065717A1 (en) * 2014-05-06 2017-03-09 Marv Enterprises, LLC Method for treating muscular dystrophy
EP2987512B1 (de) 2014-08-21 2017-03-22 Fenwal, Inc. Parallelverarbeitung von flüssigkeitsbestandteilen
CN106714669B (zh) 2014-09-22 2021-05-14 艾克塞拉医疗公司 可穿戴的血液灌流装置
WO2017075189A1 (en) 2015-10-27 2017-05-04 University Of Massachusetts Factor h-fc immunotherapy
WO2017084683A1 (en) 2015-11-20 2017-05-26 Hepa Wash Gmbh Method for extracorporeal lung support
WO2017084682A1 (en) 2015-11-20 2017-05-26 Hepa Wash Gmbh Method for extracorporeal carbon dioxide removal
US11383015B2 (en) 2016-01-11 2022-07-12 Fenwal, Inc. System and method for plasma purification prior to mononuclear cell collection
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
US10786615B2 (en) 2016-03-02 2020-09-29 Exthera Medical Corporation Method for treating drug intoxication
CN109069719B (zh) 2016-03-14 2021-11-26 阿德维托斯有限公司 用于进行透析的系统或设备和方法
US10434141B2 (en) 2016-05-31 2019-10-08 Abcentra, Llc Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
US10858422B2 (en) 2016-05-31 2020-12-08 Abcentra, Llc Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
US11596722B2 (en) 2016-07-28 2023-03-07 Captec Medical Kft. Flow capture device and method for removing cells from blood
EP3634530A1 (de) 2017-05-22 2020-04-15 Hepa Wash GmbH Verfahren und system zur entfernung von kohlendioxid
WO2019104237A1 (en) 2017-11-22 2019-05-31 Hdl Therapeutics, Inc. Systems and methods for priming fluid circuits of a plasma processing system
AU2018396009A1 (en) 2017-12-28 2020-07-16 Hdl Therapeutics, Inc. Methods for preserving and administering pre-beta high density lipoprotein extracted from human plasma
ES2722802B2 (es) * 2018-02-14 2019-12-18 Fund De Neurociencias Dispositivo para la eliminacion selectiva de moleculas de tejidos o fluidos
FR3091999A1 (fr) * 2019-01-25 2020-07-31 Mexbrain Dispositif d’extraction conjointe d’un cation métallique et d’une molécule cible
EP3930742A4 (de) * 2019-02-26 2022-12-28 Qualigen, Inc. Vorrichtung und verfahren zur vollblutbehandlung von vollblut
EP3705146A3 (de) 2019-03-05 2020-11-25 Fenwal, Inc. Entnahme von mononukleären zellen und peripheren blutstammzellen
EP3996771A1 (de) 2020-10-01 2022-05-18 Immunicom, Inc. Reduzierte auslaugung eines liganden
US11224858B1 (en) 2020-10-01 2022-01-18 Immunicom, Inc. Reduced leaching of a ligand
ES2940917B2 (es) * 2023-02-22 2023-11-30 Tecnic Biotech S L Un filtro de aféresis y un método para la eliminación de platino residual en sangre

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3453194A (en) * 1966-08-03 1969-07-01 Dow Corning Anticoagulant surfaces produced by radiation grafting heparin to a silicone substrate
US4375414A (en) * 1971-05-20 1983-03-01 Meir Strahilevitz Immunological methods for removing species from the blood circulatory system and devices therefor
US4228015A (en) * 1979-01-29 1980-10-14 Baxter Travenol Laboratories, Inc. Plasma treatment apparatus
US4215688A (en) * 1979-02-09 1980-08-05 Baxter Travenol Laboratories, Inc. Apparatus for the extracorporeal treatment of disease
US4362155A (en) * 1981-03-24 1982-12-07 Skurkovich Simon V Method and apparatus for the treatment of autoimmune and allergic diseases
US4714556A (en) * 1981-06-29 1987-12-22 Ambrus Clara M Blood purification
US4612122A (en) * 1981-06-29 1986-09-16 Clara Ambrus Removing heavy metal ions from blood
US5091091A (en) * 1981-11-06 1992-02-25 Terman David S Protein A perfusion and post perfusion drug infusion
US4637880A (en) * 1981-11-30 1987-01-20 Cordis Laboratories, Inc. Apparatus and method for therapeutic immunodepletion
US4737544A (en) * 1982-08-12 1988-04-12 Biospecific Technologies, Inc. Biospecific polymers
US4627915A (en) * 1983-04-06 1986-12-09 Asahi Kasei Kogyo Kabushiki Kaisha Absorbent of autoantibody and immune complexes, adsorbing device and blood purifying apparatus comprising the same
US4551435A (en) * 1983-08-24 1985-11-05 Immunicon, Inc. Selective removal of immunospecifically recognizable substances from solution
US4614513A (en) * 1984-08-13 1986-09-30 Fred Hutchinson Cancer Research Center Method and apparatus for treatment to remove immunoreactive substances from blood
SE459503B (sv) * 1985-05-03 1989-07-10 Excorim Kommanditbolag Hybrid-dna-molekyl innefattande dna-sekvens som kodar foer protein g samt foerfarande foer framstaellning av protein g
US5061237A (en) * 1985-07-02 1991-10-29 Cytomed Medizintechnik Gmbh Method of purifying whole blood
US4770784A (en) * 1985-11-29 1988-09-13 The Standard Oil Company Scrubbing process for high feed concentrations
EP0269279A3 (de) 1986-11-21 1988-09-14 Imre Corporation Ausserkörperliche Beseitigung von Immunoglobulin-G und zirkulierenden Immunkomplexen
US5782792A (en) * 1986-11-21 1998-07-21 Cypress Bioscience, Inc. Method for treatment of rheumatoid arthritis
DE3705637A1 (de) * 1987-02-21 1988-09-29 Bissendorf Peptide Gmbh Vorrichtung zur entfernung von lokal applizierten wirkstoffen gegen solide tumoren
US5258503A (en) * 1987-09-08 1993-11-02 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Autoantibody adsorbent and apparatus for removing autoantibodies using the same
US4865841A (en) * 1987-10-23 1989-09-12 Imre Corporation Methods and compositions for transient elimination of humoral immune antibodies
JP2566325B2 (ja) 1987-11-20 1996-12-25 クリエイティブ・バイオマリキュールズ・インコーポレーテッド 免疫複合体の選択的除去
ATE134880T1 (de) * 1988-04-04 1996-03-15 Lawrence A Potempa Bindung von immunkomplexen durch modifizierte formen von c-reaktiven proteinen
WO1989012390A1 (en) * 1988-06-20 1989-12-28 E.I. Du Pont De Nemours And Company Biocompatible, substance-specific reagents for treating physiological fluids
AU4511189A (en) * 1988-10-25 1990-05-14 Invitron Corporation Specific removal of ldl from blood
ATE233100T1 (de) * 1989-08-02 2003-03-15 Mitra Medical Technology Ab System zur verwendung in einem verfahren zur therapeutischen und diagnostischen behandlung
US5196324A (en) * 1989-12-15 1993-03-23 Eli Lilly And Company Monoclonal antibodies reactive with a human atheroma associated antigen
US5187010A (en) * 1990-11-27 1993-02-16 W. R. Grace & Co.-Conn. Membrane having high affinity for low density lipoprotein-cholesterol from whole blood
US5211850A (en) * 1991-07-26 1993-05-18 Research Medical, Inc. Plasma filter sorbent system for removal of components from blood
US5626843A (en) * 1993-02-26 1997-05-06 Advanced Biotherapy Concepts, Inc. Treatment of autoimmune diseases, including AIDS, by removel of interferons, TNFs and receptors therefor
US5753227A (en) * 1993-07-23 1998-05-19 Strahilevitz; Meir Extracorporeal affinity adsorption methods for the treatment of atherosclerosis, cancer, degenerative and autoimmune diseases
US6099730A (en) * 1997-11-14 2000-08-08 Massachusetts Institute Of Technology Apparatus for treating whole blood comprising concentric cylinders defining an annulus therebetween

Also Published As

Publication number Publication date
US6676622B2 (en) 2004-01-13
EP0710135B1 (de) 2008-11-26
EP0710135A4 (de) 1997-05-21
US6264623B1 (en) 2001-07-24
US20010039392A1 (en) 2001-11-08
IL110382A (en) 1998-12-06
EP0710135A1 (de) 1996-05-08
AU7472594A (en) 1995-02-20
US20020019603A1 (en) 2002-02-14
WO1995003084A2 (en) 1995-02-02
US6039946A (en) 2000-03-21
US5753227A (en) 1998-05-19
WO1995003084A3 (en) 1995-03-16
US20040220508A1 (en) 2004-11-04
IL110382A0 (en) 1994-12-29
US6569112B2 (en) 2003-05-27

Similar Documents

Publication Publication Date Title
DE69435170D1 (de) Extrakorporeale Vorrichtungen zur Adsorption durch Affinität
DE69407206T2 (de) Entfeuchter
DE69422967D1 (de) Einrichtung zur Bildkodierung
DE69106100T2 (de) Verfahren zur Trennung durch Adsorption und Adsorber.
DK142194A (da) Fremgangsmåde til affinitetsseparering
KR940015773U (ko) 자력 흡착기
DE69427589D1 (de) Neue zusammensetzung
DE69404652D1 (de) Analysegerät
DE9308570U1 (de) Abstellvorrichtung für Zweiräder
DE69424871T2 (de) Mechanische gasspülvorrichtung
NO932152D0 (no) Adsorpsjonsfilter
DE9306843U1 (de) Einrichtung zur Lageveränderung von Bauteilen
KR950010199U (ko) 흡착장치
KR950014726U (ko) 흡착기
KR940027550U (ko) 탈심 장치
UA350S (uk) Апарат сорбційний
KR950019673U (ko) 자동차용 2웨이 밸브(Two-WAY VALVE)
KR950007046U (ko) 카 오디오용 노브
KR950022931U (ko) 부품의 흡착장치
KR950015896U (ko) 흡착식 전화기
KR940024307U (ko) 밸브용 여과장치
KR940026677U (ko) 궤도차량용 분리밸브
LV10623A (lv) N,N-dietilaminooksipropoksi-lignina hiorhidrats - holetriola (holskabes) sorbents
KR950011046U (ko) 흡착 겸용 납땜 인두기
ATA191093A (de) Beatmungseinrichtung für mund-zu-mund-beatmung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition